ArticleCancer biology & therapy2023

Dysregulation of the circ_0087502/miR-1179/TGFBR2 pathway supports gemcitabine resistance in pancreatic cancer.

Mingliu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.